X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
breast cancer (29) 29
oncology (29) 29
humans (27) 27
index medicus (26) 26
female (20) 20
middle aged (18) 18
aged (16) 16
adult (14) 14
breast neoplasms - drug therapy (14) 14
chemotherapy (13) 13
medicine & public health (13) 13
metastasis (12) 12
cancer (10) 10
care and treatment (10) 10
therapy (10) 10
breast neoplasms - pathology (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
cancer research (8) 8
epidermal growth factor (8) 8
patients (8) 8
surgery (8) 8
surgical oncology (8) 8
antineoplastic agents (7) 7
apoptosis (7) 7
erbb-2 protein (7) 7
survival (7) 7
treatment outcome (7) 7
analysis (6) 6
antimitotic agents (6) 6
cancer therapies (6) 6
lung neoplasms - pathology (6) 6
neoadjuvant chemotherapy (6) 6
obstetrics & gynecology (6) 6
original (6) 6
receptor, erbb-2 - metabolism (6) 6
research (6) 6
trial (6) 6
women (6) 6
aged, 80 and over (5) 5
animals (5) 5
anthracycline (5) 5
antineoplastic agents - therapeutic use (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
carcinoma, non-small-cell lung - pathology (5) 5
docetaxel (5) 5
endocrine therapy (5) 5
hematology, oncology and palliative medicine (5) 5
male (5) 5
medicine, research & experimental (5) 5
mice (5) 5
neoadjuvant therapy (5) 5
oncology, experimental (5) 5
paclitaxel (5) 5
trastuzumab (5) 5
anthracyclines (4) 4
cancer patients (4) 4
capecitabine (4) 4
carcinoma, non-small-cell lung - metabolism (4) 4
clinical trials (4) 4
gene expression (4) 4
gene-expression (4) 4
health aspects (4) 4
her2 (4) 4
medical prognosis (4) 4
neoplasm staging (4) 4
neutropenia (4) 4
open-label (4) 4
original article (4) 4
post-menopause (4) 4
prognosis (4) 4
receptors, estrogen - metabolism (4) 4
safety (4) 4
taxane (4) 4
time factors (4) 4
tumors (4) 4
xenograft model antitumor assays (4) 4
adenoviridae - genetics (3) 3
adjuvant chemotherapy (3) 3
adjuvant treatment (3) 3
advanced breast cancer (3) 3
anthracyclines - therapeutic use (3) 3
antineoplastic agents - adverse effects (3) 3
breast neoplasms - genetics (3) 3
breast neoplasms - surgery (3) 3
carcinoma, non-small-cell lung - genetics (3) 3
carcinoma, non-small-cell lung - therapy (3) 3
cell line, tumor (3) 3
clinical trial (3) 3
cyclophosphamide (3) 3
drug dosages (3) 3
efficacy (3) 3
epirubicin (3) 3
eribulin (3) 3
genes, p53 - genetics (3) 3
hormones (3) 3
japanese (3) 3
lung neoplasms - genetics (3) 3
lung neoplasms - metabolism (3) 3
medicine, general & internal (3) 3
metastases (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 22, pp. 2147 - 2159
Journal Article
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 1/2014, Volume 143, Issue 2, pp. 403 - 409
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 1/2019, Volume 173, Issue 1, pp. 123 - 133
Journal Article
BMC CANCER, ISSN 1471-2407, 10/2019, Volume 19, Issue 1, pp. 962 - 8
Background We previously reported the synergistic effect of S-1 and eribulin in preclinical models. In addition, our phase I study revealed the recommended... 
Eribulin | PROGNOSTIC-FACTORS | 1ST-LINE CHEMOTHERAPY | Breast cancer | OPEN-LABEL | GEMCITABINE | PACLITAXEL | TRIAL | Phase II study | HEPATIC METASTASES | ONCOLOGY | GASTRIC-CANCER | ANTHRACYCLINE | S-1 | TAXANE | TNBC | Receptors, Estrogen - metabolism | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Furans - adverse effects | Furans - therapeutic use | Antimetabolites, Antineoplastic - administration & dosage | Taxoids - therapeutic use | Adult | Female | Ketones - therapeutic use | Ketones - adverse effects | Bridged-Ring Compounds - therapeutic use | Tegafur - adverse effects | Tegafur - therapeutic use | Ketones - administration & dosage | Oxonic Acid - administration & dosage | Breast Neoplasms - drug therapy | Oxonic Acid - adverse effects | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Oxonic Acid - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Tegafur - administration & dosage | Aged | Anthracyclines - therapeutic use | Drug Combinations | Furans - administration & dosage | Usage | Care and treatment | Safety and security measures | Prognosis | Analysis | Clinical trials | Eribulin mesylate
Journal Article
Breast Cancer, ISSN 1340-6868, 1/2018, Volume 25, Issue 1, pp. 108 - 117
... • Norikazu Masuda 3 • Akiyo Yoshimura 1 • Shoichiro Ohtani 4 • Hiroyuki Yasojima 3 • Satoshi Morita 5 • Shinji Ohno 6 • Hiroji Iwata 1 Received: 10 March 2017 / Accepted... 
Eribulin | Medicine & Public Health | Capecitabine | Surgery | Oncology | Cancer Research | Breast cancer | Pharmacokinetics | Surgical Oncology | Metastases | MONOTHERAPY | EFFICACY | SAFETY | OBSTETRICS & GYNECOLOGY | MESYLATE | HALICHONDRIN B ANALOG | THERAPY | ONCOLOGY | ANTHRACYCLINE | JAPANESE | TAXANE | Anthracyclines | Oncology, Experimental | Research | Metastasis | Uric acid | Cancer | Index Medicus | Original
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 8/2015, Volume 20, Issue 4, pp. 709 - 722
Journal Article
Breast Cancer: Basic and Clinical Research, ISSN 1178-2234, 1/2019, Volume 13, p. 1178223418825135
Purpose: To investigate the clinical predictive factors for the efficacy of everolimus (EVE) for advanced/metastatic breast cancer (AMBC). Methods: Routine... 
hormone sensitivity | cohort study | advanced breast cancer | Everolimus
Journal Article
Breast Cancer, ISSN 1340-6868, 1/2018, Volume 25, Issue 1, pp. 126 - 126
...: JBCRG-18 cape study”, written by Masaya Hattori, Hiroshi Ishiguro, Norikazu Masuda, Akiyo Yoshimura, Shoichiro Ohtani, Hiroyuki Yasojima, Satoshi Morita, Shinji Ohno, and Hiroji Iwata, was originally published... 
Oncology | Cancer Research | Medicine & Public Health | Surgical Oncology | Surgery | Web portals | Antimitotic agents | Oncology, Experimental | Breast cancer | Research | Metastasis | Antineoplastic agents | Cancer
Journal Article
Clinical and Translational Medicine, ISSN 2001-1326, 12/2017, Volume 6, Issue 1, pp. 1 - 8
Surgery/anesthetic technique-stimulated immunosuppression may be associated with outcome for cancer patients. Here, the immune responses of patients undergoing... 
Immune response | Medicine & Public Health | Anesthetic | Hospitalization surgery | Day surgery | Breast cancer | Medicine/Public Health, general | MEDICINE, RESEARCH & EXPERIMENTAL | MEDIATING MECHANISMS | APOPTOSIS | NATURAL-KILLER | METASTASIS | AFFECT RECURRENCE | PROPOFOL | KETAMINE | ONCOLOGY | LIDOCAINE | FENTANYL | ANALGESIA | Anesthesia | Hospitalization | Narcotics | Surgery
Journal Article
Nihon Rinshō Geka Gakkai zasshi, ISSN 1345-2843, 2017, Volume 78, Issue 2, pp. 239 - 245
Journal Article
Journal Article